207 related articles for article (PubMed ID: 24330428)
21. De novo discovery of mutated driver pathways in cancer.
Vandin F; Upfal E; Raphael BJ
Genome Res; 2012 Feb; 22(2):375-85. PubMed ID: 21653252
[TBL] [Abstract][Full Text] [Related]
22. Predicting the functional consequences of somatic missense mutations found in tumors.
Carter H; Karchin R
Methods Mol Biol; 2014; 1101():135-59. PubMed ID: 24233781
[TBL] [Abstract][Full Text] [Related]
23. QuaDMutNetEx: a method for detecting cancer driver genes with low mutation frequency.
Bokhari Y; Alhareeri A; Arodz T
BMC Bioinformatics; 2020 Mar; 21(1):122. PubMed ID: 32293263
[TBL] [Abstract][Full Text] [Related]
24. A computational approach to distinguish somatic vs. germline origin of genomic alterations from deep sequencing of cancer specimens without a matched normal.
Sun JX; He Y; Sanford E; Montesion M; Frampton GM; Vignot S; Soria JC; Ross JS; Miller VA; Stephens PJ; Lipson D; Yelensky R
PLoS Comput Biol; 2018 Feb; 14(2):e1005965. PubMed ID: 29415044
[TBL] [Abstract][Full Text] [Related]
25. Discovering potential cancer driver genes by an integrated network-based approach.
Shi K; Gao L; Wang B
Mol Biosyst; 2016 Aug; 12(9):2921-31. PubMed ID: 27426053
[TBL] [Abstract][Full Text] [Related]
26. Distinguishing between driver and passenger mutations in individual cancer genomes by network enrichment analysis.
Merid SK; Goranskaya D; Alexeyenko A
BMC Bioinformatics; 2014 Sep; 15(1):308. PubMed ID: 25236784
[TBL] [Abstract][Full Text] [Related]
27. Looking beyond drivers and passengers in cancer genome sequencing data.
De S; Ganesan S
Ann Oncol; 2017 May; 28(5):938-945. PubMed ID: 27998972
[TBL] [Abstract][Full Text] [Related]
28. Modeling cancer driver events in vitro using barrier bypass-clonal expansion assays and massively parallel sequencing.
Huskova H; Ardin M; Weninger A; Vargova K; Barrin S; Villar S; Olivier M; Stopka T; Herceg Z; Hollstein M; Zavadil J; Korenjak M
Oncogene; 2017 Oct; 36(43):6041-6048. PubMed ID: 28692054
[TBL] [Abstract][Full Text] [Related]
29. Mutator phenotype in cancer: timing and perspectives.
Bielas JH; Loeb LA
Environ Mol Mutagen; 2005; 45(2-3):206-13. PubMed ID: 15672382
[TBL] [Abstract][Full Text] [Related]
30. The mini-driver model of polygenic cancer evolution.
Castro-Giner F; Ratcliffe P; Tomlinson I
Nat Rev Cancer; 2015 Nov; 15(11):680-5. PubMed ID: 26456849
[TBL] [Abstract][Full Text] [Related]
31. Identification of mutated core cancer modules by integrating somatic mutation, copy number variation, and gene expression data.
Zhang J; Zhang S; Wang Y; Zhang XS
BMC Syst Biol; 2013; 7 Suppl 2(Suppl 2):S4. PubMed ID: 24565034
[TBL] [Abstract][Full Text] [Related]
32. Identification of candidate cancer drivers by integrative Epi-DNA and Gene Expression (iEDGE) data analysis.
Li A; Chapuy B; Varelas X; Sebastiani P; Monti S
Sci Rep; 2019 Nov; 9(1):16904. PubMed ID: 31729402
[TBL] [Abstract][Full Text] [Related]
33. Cancer genome landscapes.
Vogelstein B; Papadopoulos N; Velculescu VE; Zhou S; Diaz LA; Kinzler KW
Science; 2013 Mar; 339(6127):1546-58. PubMed ID: 23539594
[TBL] [Abstract][Full Text] [Related]
34. Circuits of cancer drivers revealed by convergent misregulation of transcription factor targets across tumor types.
Gonzalez-Perez A
Genome Med; 2016 Jan; 8(1):6. PubMed ID: 26792175
[TBL] [Abstract][Full Text] [Related]
35. SNP array profiling of childhood adrenocortical tumors reveals distinct pathways of tumorigenesis and highlights candidate driver genes.
Letouzé E; Rosati R; Komechen H; Doghman M; Marisa L; Flück C; de Krijger RR; van Noesel MM; Mas JC; Pianovski MA; Zambetti GP; Figueiredo BC; Lalli E
J Clin Endocrinol Metab; 2012 Jul; 97(7):E1284-93. PubMed ID: 22539591
[TBL] [Abstract][Full Text] [Related]
36. Domain landscapes of somatic mutations in cancer.
Nehrt NL; Peterson TA; Park D; Kann MG
BMC Genomics; 2012 Jun; 13 Suppl 4(Suppl 4):S9. PubMed ID: 22759657
[TBL] [Abstract][Full Text] [Related]
37. Identifying driver mutations from sequencing data of heterogeneous tumors in the era of personalized genome sequencing.
Zhang J; Liu J; Sun J; Chen C; Foltz G; Lin B
Brief Bioinform; 2014 Mar; 15(2):244-55. PubMed ID: 23818492
[TBL] [Abstract][Full Text] [Related]
38. Cancer driver mutations in protein kinase genes.
Torkamani A; Verkhivker G; Schork NJ
Cancer Lett; 2009 Aug; 281(2):117-27. PubMed ID: 19081671
[TBL] [Abstract][Full Text] [Related]
39. Genome destabilizing mutator alleles drive specific mutational trajectories in Saccharomyces cerevisiae.
Stirling PC; Shen Y; Corbett R; Jones SJ; Hieter P
Genetics; 2014 Feb; 196(2):403-12. PubMed ID: 24336748
[TBL] [Abstract][Full Text] [Related]
40. Adaptation of a mutual exclusivity framework to identify driver mutations within oncogenic pathways.
Wang X; Kostrzewa C; Reiner A; Shen R; Begg C
Am J Hum Genet; 2024 Feb; 111(2):227-241. PubMed ID: 38232729
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
